131 related articles for article (PubMed ID: 37949021)
21. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
22. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
Ozturk K; Nascene D
AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
[TBL] [Abstract][Full Text] [Related]
25. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
[TBL] [Abstract][Full Text] [Related]
26. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
[TBL] [Abstract][Full Text] [Related]
28. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
[TBL] [Abstract][Full Text] [Related]
29. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
30. Does renal function affect gadolinium deposition in the brain?
Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
[TBL] [Abstract][Full Text] [Related]
31. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
32. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
33. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary observation on the changes of T(1) weighted signal of globus pallidus after multiple intravenous injection of linear gadolinium contrast agent].
Kong Y; Xu K; Ye XC; Han CP; Li MS; Chen ZD
Zhonghua Yi Xue Za Zhi; 2019 May; 99(19):1468-1472. PubMed ID: 31137136
[No Abstract] [Full Text] [Related]
35. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
[TBL] [Abstract][Full Text] [Related]
36. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Pozeg P; Forget J; Meuli RA; Maeder P
Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
[TBL] [Abstract][Full Text] [Related]
37. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
[TBL] [Abstract][Full Text] [Related]
38. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
40. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
